Fineotex Chemical Limited (NSE:FCL)
India · Delayed Price · Currency is INR 39.99
+1.43 (3.71%)
May 29, 2026, 3:30 PM IST
Fineotex Chemical Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 7,722 | 5,333 | 5,690 | 5,170 | 3,682 |
Other Revenue | - | - | - | 1.29 | - |
| 7,722 | 5,333 | 5,690 | 5,171 | 3,682 | |
Revenue Growth (YoY) | 44.79% | -6.26% | 10.03% | 40.43% | 67.62% |
Cost of Revenue | 5,174 | 3,286 | 3,516 | 3,418 | 2,370 |
Gross Profit | 2,549 | 2,047 | 2,173 | 1,753 | 1,312 |
Selling, General & Admin | 403.55 | 289.22 | 250.78 | 214.79 | 160.88 |
Other Operating Expenses | 797.6 | 478.38 | 436.83 | 407.53 | 432.4 |
Operating Expenses | 1,335 | 859.81 | 747.81 | 665.11 | 618.41 |
Operating Income | 1,213 | 1,187 | 1,426 | 1,088 | 693.87 |
Interest Expense | -13.62 | -2.42 | -3.45 | -2.08 | -2.78 |
Interest & Investment Income | - | 31.31 | 19.68 | 10.53 | 9.74 |
Currency Exchange Gain (Loss) | - | 10.58 | 11.79 | 18.12 | 4.97 |
Other Non Operating Income (Expenses) | 330.7 | -5.01 | -6.23 | 33.04 | 27.08 |
EBT Excluding Unusual Items | 1,530 | 1,222 | 1,447 | 1,148 | 732.87 |
Gain (Loss) on Sale of Investments | - | 190.65 | 128.26 | - | 0.01 |
Pretax Income | 1,530 | 1,412 | 1,576 | 1,148 | 732.88 |
Income Tax Expense | 280.18 | 320.35 | 365.42 | 252.44 | 163.98 |
Earnings From Continuing Operations | 1,250 | 1,092 | 1,210 | 895.55 | 568.9 |
Minority Interest in Earnings | -162.63 | -10 | -12.16 | -12.39 | -17.15 |
Net Income | 1,088 | 1,082 | 1,198 | 883.16 | 551.74 |
Net Income to Common | 1,088 | 1,082 | 1,198 | 883.16 | 551.74 |
Net Income Growth | 0.50% | -9.68% | 35.66% | 60.07% | 29.55% |
Shares Outstanding (Basic) | 998 | 1,136 | 1,108 | 1,107 | 1,107 |
Shares Outstanding (Diluted) | 998 | 1,136 | 1,108 | 1,107 | 1,107 |
Shares Change (YoY) | -12.16% | 2.56% | 0.00% | - | -0.20% |
EPS (Basic) | 1.09 | 0.95 | 1.08 | 0.80 | 0.50 |
EPS (Diluted) | 1.09 | 0.95 | 1.08 | 0.80 | 0.50 |
EPS Growth | 14.41% | -11.93% | 35.65% | 60.07% | 29.82% |
Free Cash Flow | -483.75 | -73.46 | 491.4 | 878.37 | -91.37 |
Free Cash Flow Per Share | -0.48 | -0.07 | 0.44 | 0.79 | -0.08 |
Dividend Per Share | 0.130 | 0.080 | 0.160 | 0.080 | 0.040 |
Dividend Growth | 62.50% | -50.00% | 100.00% | 100.00% | 33.33% |
Gross Margin | 33.00% | 38.38% | 38.20% | 33.91% | 35.64% |
Operating Margin | 15.71% | 22.26% | 25.06% | 21.05% | 18.84% |
Profit Margin | 14.08% | 20.29% | 21.06% | 17.08% | 14.98% |
Free Cash Flow Margin | -6.26% | -1.38% | 8.64% | 16.99% | -2.48% |
EBITDA | 1,347 | 1,280 | 1,486 | 1,131 | 719 |
EBITDA Margin | 17.45% | 23.99% | 26.11% | 21.87% | 19.53% |
D&A For EBITDA | 134.25 | 92.21 | 60.2 | 42.8 | 25.13 |
EBIT | 1,213 | 1,187 | 1,426 | 1,088 | 693.87 |
EBIT Margin | 15.71% | 22.26% | 25.06% | 21.05% | 18.84% |
Effective Tax Rate | 18.31% | 22.68% | 23.19% | 21.99% | 22.38% |
Revenue as Reported | 8,053 | 5,576 | 5,855 | 5,243 | 3,737 |
Advertising Expenses | - | 11.6 | 6.17 | 2.77 | 3.83 |